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 For years, developmental biology has been in search of an understanding as to 
how an organism undergoes cellular differentiation to produce distinct cell types. Bacillus 
subtilis is a bacterial organism that undergoes cellular differentiation during a process 
known as sporulation.  B. subtilis is the most studied spore-forming bacterium and is used 
as a model for cell fate and development. 
Without the availability of glucose as the preferred carbon source, B. subtilis must 
turn to other sources of carbon in order to generate the energy needed for the process of 
sporulation.  One operon in its genome that may be devoted to the breakdown of fatty 
acids for energy during sporulation is the mother cell metabolic gene (mmg) operon.  This 
operon consists of mmgABCDE and yqiQ, all of which are presumably involved in either 
fatty acid metabolism or the (methyl)citric acid cycle. 
Two genes in this operon, mmgC and mmgB show similarity to acyl-coenzyme A 
dehydrogenase and β-hydroxyacyl-coenzyme A dehydrogenase, respectively.  Both 
mmgC and mmgB have been successfully cloned, overexpressed, and purified from B. 
subtilis strain 168.  MmgC has also been biochemically characterized and determined to 
be a short chain acyl-coenzyme A dehydrogenase.  Furthermore, MmgC showed 
specificity toward isobutyryl-coenzyme A over butyryl-coenzyme A.  MmgB, on the 
other hand, did not show any activity for the dehydrogenation of β-hydroxybutyryl-
coenzyme A. 
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CHAPTER I 
 
INTRODUCTION
 
 
I.A Sporulation in Bacillus subtilis 
 
Bacillus subtilis is an aerobic, endospore-forming, rod shaped bacterium that is 
the best-characterized member of the Gram-positive bacteria.  They are commonly found 
in soil, water, and in association with plants. Since Bacillus strains have a great capacity 
to secrete large amounts of enzymes, they are important to the environment, medicine, 
and industry1.   
The Bacillus genome consists of 4,214,810 base pairs, which comprise 4,100 
protein coding sequences (CDSs).1  These 4,100 CDSs comprise 87% of the genome 
sequence and each CDS has an average size of 890 base pairs.1  Fifty-eight percent of  the 
B. subtilis gene products have been assigned based on significant counterpart.1  This 
leaves forty-two percent of the gene products that cannot be assigned a function based on 
sequence homology alone.   
A large portion of the B. subtilis genome is devoted to the utilization of a variety 
of different carbon sources.  However, when faced with nutritional starvation, B. subtilis 
initiates responses to restore growth by increasing metabolic diversity.  These responses 
can include the induction of flagellar motility to seek out new food sources through 
chemotaxis, the production and excretion of macromolecular hydrolases, including 
proteases and carbohydrases to scavenge any extracellular proteins and polysaccharides, 
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the production of antibiotics to kill any competing microbes, and the induction of 
competency for the uptake of exogenous DNA for consumption.1, 2  If the above 
responses, invoked through nutritional starvation, prove inadequate, the cells are induced 
into a process known as sporulation, resulting in the formation of spores.  Spores are 
small metabolically inactive cells that are resistant to heat, desiccation, radiation, and 
chemical insult.2   
Sporulation involves a perturbation of the normal cell cycle and the differentiation 
of a binucleate cell into two cell types1.  The two cell types include a forespore and a 
mother cell; each containing an entire copy of the chromosome.  Entry into sporulation 
involves the formation of an axial filament.3  The axial filament consists of two copies of 
the chromosome that stretch along the entire length of the cell.4  A septum is formed next 
and is located at a polar position.3  After septation, the forespore becomes engulfed by the 
mother cell3 and becomes a free-floating protoplast within the mother cell.4  At this time, 
the forespore is now referred to as an endospore and is only encased by two membranes.  
Through another series of biosynthetic and morphological stages, the endospore is 
protected with a germ cell wall and cortex, a spore coat, and other protective layers of 
protein.4  After this maturation process, the mother cell is lysed and the mature spore is 
released.  A schematic of spore formation can be seen in Figure 1. 
 3
Mother Cell Mother Cell
Forespore1. Vegetative Growth
2. Septation 3. Engulfment
4. Spore Protection
5. Spore Release
 
Figure 1. Sporulation of Bacillus subtilis.  See text for a description of the events taking place during 
sporulation.   
I.B Sigma Factors Involved in Sporulation 
 
In bacteria, there is only one RNA polymerase responsible for the transcription of 
all RNA.5  The core of the RNA polymerase is a multi-subunit enzyme, consisting of 
α2ββ’ω.6  Although the core RNA polymerase itself is capable of synthesizing RNA, it is 
able to recognize specific promoter regions on DNA with the binding of a σ subunit.7  
Specific gene recognition allows for the control of sporulation, as different subsets of 
genes are spatially and temporally regulated so that expression occurs not only in the 
correct compartment but also at the correct time in development.8  During the sporulation 
process, there is a sequential activation of different σ subunits of RNA polymerase.  Each 
σ factor is then responsible for gene recognition by RNA polymerase.  The particular 
genes that are transcribed are then ultimately responsible for the series of morphological 
changes that results in sporulation.  The different σ factors activated throughout 
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sporulation include A,H,E,F,G, and K,9 and the time of their activation is illustrated 
below in Figure 2. 
 
Figure 2. Sigma Factor Activation.  A schematic showing the relative activation times of the different 
sigma factors during sporulation.  See Fig 1. for a description of the events during sporulation. 
The entire process of sporulation contains a “complex network of interconnected 
regulatory pathways and developmental checkpoints.”1  However, it is known that the 
initiation of sporulation ultimately depends on the Spo0A transcription factor; a typical 
‘response regulator’ component of the two component signaling systems that are 
prevalent in bacteria.2  The activity of the response regulator is dependent on 
phosphorylation, which is induced during nutritional starvation, increased cell density, 
and other cell cycle signals.  An elevated level of Spo0A induces sporulation by 
activating the transcription factors σA and σH.9 
σA and σH appear during vegetative growth and are required for the initiation of 
sporulation.9,10  σA and σH direct the transcription of genes whose products direct the 
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septum formation to the polar position.9  σA and σH are also responsible for the 
partitioning of a chromosomal copy in the mother cell as well as the forespore.9   
σE and σF are synthesized in the predivisional sporangium, however, they do not 
become active until polar division.11   σE is activated specifically in the mother cell 
following asymmetric septation.4, 9  Furthermore, σE is first synthesized in its inactive 
state, pro-σE.  In response to a signal from the prespore,4 it is activated by proteolytic 
cleavage of 27-29 residues from the N-terminus of pro- σE.9, 12  This is the first sign of 
communication between the mother cell and prespore during sporulation.4  The removal 
of the N-terminal domain of the peptide is under the control of the integral protein 
SpoIIGA.11  After septum formation, σF becomes active in the forespore, while σE 
becomes active in the mother cell.9, 11  σE and σF can be attributed to the dissimilar fates 
of the forespore and the mother cell.11  The products of the genes regulated by σE and σF 
are responsible for the engulfment of the forespore into the mother cell.   
Once engulfed, σG becomes active in the forespore and its genes are responsible 
for the preparation of the chromosome for protection and germination.9  After σG 
activation, σK becomes active in the mother cell, and together with σE, the forespore is 
provided with a cortex and several coat proteins.9  σK is also believed to be responsible 
for genes involved in the lysis of the mother cell, releasing the mature spore.9   
The sigma factors involved in the sporulation of B. subtilis control many genes 
within its genome and allow it to undergo this biotransformation.  However, many of the 
genes under the control of these sigma factors are not known with complete certainty and 
many of the proposed functions are based on sequence homology alone.  Likewise, many 
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of the genes show no sequence homology with any understood counterpart and cannot be 
assigned any function.  The sporulation of B. subtilis is very complex and little is known 
about how all the genes biochemically contribute to the sporulation process.   
I.C The Mother Cell Metabolic Gene Operon 
Bryan, et al, were able to identify genes expressed at intermediate stages of 
sporulation by screening for σE – dependent promoters.13  σE is in control of 253 genes, 
which are organized into 157 operons.14  One operon was shown to drive the expression 
of six different open reading frames (ORFs).  The transcription of the genes that Bryan, et 
al, found are dependent on the mother-cell-specific sigma factor, σE, so the operon was 
named mother cell metabolic genes (mmg).13   The sequence of the transcription unit 
revealed six ORFs and the ORFs were named mmgA, mmgB, mmgC, mmgD, mmgE, and 
yqiQ.13, 14  The transcription of these genes are regulated by mmgO and CcpA.13  MmgO 
is a 14-base pair (bp) catabolite response element centered 22-bps downstream from the 
mmg transcriptional start site.13  CcpA is a protein that binds to mmgO in order to mediate 
glucose repression of mmg promoter activity.13  From the work of Bryan, et al, it was 
shown that mmgO is required for glucose repression of the mmg promoter during 
sporulation and that CcpA is required for glucose repression of mmg promoter activity; 
CcpA binds to mmgO in order to regulate mmg promoter activity.  Knowing this, it seems 
logical that the genes in this operon may be related to energy production during 
sporulation because their transcription is regulated in response to carbon source 
availability.  
 7
Based on sequence homology, the genes of the mmg operon can be assigned 
preliminary functions.  The products of mmgA, mmgB, and mmgC are similar to enzymes 
known to be involved in fatty acid metabolism.  MmgA is an acetyl-Coenzyme A (CoA) 
thiolase15, mmgB shows sequence similarity to 3-hydroxybutyryl-CoA (HB-CoA) 
dehydrogenase, and mmgC shows sequence similarity to acyl-CoA (Ac-CoA) 
dehydrogenase.13, 14  MmgD shows similarity to citrate synthases.13, 14  MmgE shows 
sequence similarity to 2-methylcitrate dehydratase and YqiQ shows greatest similarity to 
the aldolase, methylisocitrate lyase.  The sequence similarity of these genes to others 
shows that the mother cell metabolic gene operon may be used in the metabolism of 
fatty acids for the production of energy during sporulation. 
I.D Fatty Acids and Their Metabolism 
 The major constituent of bacterial cell membranes is phospholipid.  Phospholipids 
are composed of glycerol-3-phosphate whose C1 and C2 positions are esterified with 
fatty acids.  The properties of the phospholipid depend on the distribution of fatty acids 
between the 1- and 2- positions on phosphoglycerol and the nature of the phosphate 
derivative on the 3-position.16  The physical properties of the fatty acid components also 
play a significant role in the properties of the phospholipids.  The membrane fatty acids 
can be divided into two major families based on their biosynthetic relationship.  The first 
is the straight-chain fatty acid family and the other is the branched-chain fatty acid 
family.17    The straight-chain fatty acids are most common in bacteria, however, the 
occurrence of branched-chain fatty acids is still significant.17  The branched chain fatty-
acids are a major constituent of B. subtilis’ phospholipids.16-18  The most common 
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straight chain fatty acids include palmitic, stearic, oleic, linoleic, and linoletic acid.16  The 
major occurrence of terminally methyl-branched fatty acids was first reported in 196016 
to include 13-methyl-tetradecanoic acid and 15-methylhexadecanoic acid in Bacillus 
subtilis.19  Since then, several other methyl-branched fatty acids have been isolated from 
Bacillus subtilis.18  The function of branched-chain fatty acids are considered when 
determining the substrates used for phospholipid synthesis and the conformation that 
branched-chain fatty acids contribute to the fluidity of the membrane.16  The 
classification of the methyl-branched fatty acids can be grouped into three series based on 
their biosynthetic relationship.  The three series include anteiso, odd-numbered iso, and 
even-numbered iso.16  An anteiso methyl-branched fatty acid contains a methyl group on 
its ω3 carbon, while an iso methyl-branched fatty acid contains a methyl group on its ω2 
carbon.  These iso fatty acids can have either an even or odd number of carbon atoms. 
Although fatty acids are an important building block for cellular components, they 
can also be degraded to provide energy to the organism.  The steps in fatty acid 
metabolism first involve the activation of a fatty acid by creating a thioester linkage to 
Coenzyme A (CoA) and then the cycling of oxidation, hydration, oxidation, and thiolysis; 
the latter four steps are known as the β-oxidation of a fatty acid (Figure 3). An acetyl-
CoA and an acyl-CoA two carbons shorter than that of the starting acyl-CoA are 
generated after one round of β-oxidation.   
In the first step of β-oxidation, a fatty acid is first oxidized by an acyl-CoA 
dehydrogenase, forming an enoyl-CoA.  Enoyl-CoA formation involves the transfer of 
electrons to an FAD or an FMN prosthetic group of the acyl-CoA dehydrogenase, 
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forming FADH2 or FMNH2, respectively.  In the second step, enoyl-CoA is hydrated by 
an enoyl-CoA hydratase to produce a 3-hydroxyacyl-CoA.  The third step is the oxidation 
of the 3-hydroxyacyl-CoA by a dehydrogenase, with the simultaneous reduction of NAD+ 
or NADP+ to form a 3-ketoacyl-CoA and NADH or NADPH, respectively.  The final step 
involves a thiolysis in which the nucleophilic sulphur of CoA-SH attacks the carbonyl of 
the 3-ketoacyl-CoA to produce acetyl-CoA. 
 
 
Figure 3. A schematic of fatty acid metabolism.  The steps involve first an activation of a fatty acid 
and then the cycling of oxidation, reduction, oxidation, and thiolysis to produce acetyl-CoA and an 
acyl-CoA two carbons shorter than that of the starting acyl-CoA.  The resulting acyl-CoA re-enters 
the beta-oxidation cycle. 
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If the fatty acid is only 4 carbons in length and straight-chained, then one round of 
β-oxidation would produce 2 acetyl-CoAs.  However, if the fatty acid is longer than 4 
carbons in length, the thiolysis reaction would only remove a 2-carbon unit from the fatty 
acid, producing 1 acetyl-CoA and a fatty acid which is 2 carbons shorter in length.  β-
oxidation would then continue until the entire fatty acid molecule has been converted to 
acetyl-CoA.   
In the event that the fatty acid has an odd number of carbons or is anteiso 
branched, propionyl-CoA and acetyl-CoA are the ultimate products of β-oxidation.  
Acetyl-CoA can be used in the citric acid cycle for further energy production through the 
condensation with oxaloacetate to form citrate (Figure 4).  However, when propionyl-
CoA is condensed with oxaloacetate, methylcitrate is produced (Figure 4).   
By studying mutant strains of Candida lipolytica, it was shown that there is a 
separate pathway for the degradation of odd chain fatty acids.20  In E. coli and A. 
nidulans, there is also a separate regulated pathway in place to oxidize propionate to 
pyruvate: the methylcitrate cycle.21, 22  It has also been suggested that propionyl-CoA is 
converted to succinate and pyruvate through the methylcitric acid cycle in B. subtilis 
(Figure 5).23  The resulting pyruvate can then be converted to acetyl-CoA by the pyruvate 
dehydrogenase complex. 
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Figure 4. (Methyl)citrate Production.  The production of citrate and methylcitrate through a 
condensation reaction. 
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Figure 5. Methylcitric Acid Cycle.  Production of succinate and pyruvate from methylcitrate. 
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 Like all metabolic processes, sporulation involves the use of energy.  Knowing 
that sporulation is induced by nutritional starvation and carbon source depravation in B. 
subtilis, the energy required for the sporulation process must be made available through 
nontraditional metabolic processes.  Phospholipids are the major component of bacterial 
cell membranes and their metabolism can provide an organism with energy during 
nutritional starvation.  The events of fatty acid metabolism are very well studied. 
However, many of the specific genes in B. subtilis responsible for the production of 
energy during sporulation have not been biochemically characterized.  Based on the 
sequence similarity of the genes found in the mother cell metabolic gene operon to other 
characterized genes, the σE controlled mmg operon may contain information on how the 
energy used during the sporulation process of B. subtilis is derived.  The goal of this 
thesis research is to biochemically characterize two of the genes found in the mmg 
operon: mmgB and mmgC. 
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CHAPTER II 
OVEREXPRESSION AND PURIFICATION OF MmgC and MmgB FROM 
BACILLUS SUBTILIS STRAIN 168 
 
 
II.A Introduction to MmgC and MmgB 
 
 During sporulation, the σE factor controls the gene expression within the mother 
cell.  Two genes included within the 253 genes under σE control are mmgC and mmgB.14  
Based on the sequence of mmgC, it can be classified as an acyl-CoA dehydrogenase,14, 24  
while mmgB’s sequence shows similarity to other β-hydroxyacyl-CoA dehydrogenases.  
Furthermore, both of these genes are conserved in B. anthracis, B. halodurans, O. 
iheyensis, C. acetobutylicum, and C. perfringens.14 
Based on the homology of these genes and their time of activation, it is reasonable 
to conclude they are involved in the metabolism of fatty acids.  After the initial activation 
of a fatty acid, by the attachment of coenzyme A, the first step in its β-oxidation is its 
oxidation to an enoyl-CoA by an acyl-CoA dehydrogenase (MmgC).  The oxidizing 
agent typically found in an acyl-CoA dehydrogenase is either FMN or FAD.  The fatty 
acid is then subject to hydration to form a hydroxyacyl-CoA, and then through a 
subsequent reaction the hydroxyacyl-CoA is dehydrogenated to form a β-ketoacyl-CoA, 
which is presumably the role of MmgB.  Following the dehydrogenation by MmgB is the 
thiolysis of the acetoacetyl-CoA by MmgA to produce acetyl-CoA and an acyl-CoA.15 
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II.A.1 Goals 
 
The first goal of this research was to clone and over-express mmgC and mmgB.  
The second goal was to purify the mmgC and mmgB proteins.  Using the purified protein, 
the last goal was to characterize the activities of MmgC and MmgB.   
In order to clone mmgC and mmgB, a polymerase chain reaction was performed to 
produce a large quantity of the gene sequence.  After successful PCR, the gene was 
inserted into a host vector.  We choose pET-28a as a suitable vector in which to insert the 
gene.  This vector allows overexpression of genes using the bacteriophage T7 promoter 
and T7 RNA polymerase.25  A suitable host for this plasmid is the E. coli strain 
BL21(DE3).  E. coli BL21 has been infected as the λDE3 lysogen.  A λDE3 lysogen has 
a T7 RNA polymerase downstream from a lac promoter.  The E. coli genome already 
contains a lacI gene, which produces a lac repressor protein.  This lac repressor protein 
inhibits the binding of E. coli RNA polymerase to the lac promoter region and therefore 
inhibits the transcription of the T7 gene to produce T7 RNA polymerase.  Furthermore, 
pET-28a also contains the lacI gene, making this a high fidelity system.  The addition of 
isopropyl-beta-D-thiogalactopyranoside (IPTG) removes the lac repressor protein from 
the lac promoter sequence and allows E. coli RNA polymerase to bind.  As the region is 
transcribed, and consequently translated, T7 RNA polymerase is produced.  The T7 RNA 
polymerase produced from the host E. coli DNA can then recognize the T7 promoter 
region of the pET-28a plasmid and transcribe the target gene sequence directly 
downstream from the promoter region.  A schematic of cloning and expression using this 
system can be seen in Figure 625. 
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Figure 6. 25 Protein Expression System.  
 Once mmgC and mmgB are successfully cloned and overexpressed, the mmgC and 
mmgB gene products need to be purified.  During the cloning process, six histidine (His6) 
residues would have been attached to either the C- or N-terminus of the gene. Because of 
the His6 tag present on MmgC and MmgB, QIAGEN’s patented nickel-nitrilotriacetic 
acid (Ni-NTA) metal-affinity chromatography methods can be used to purify the protein 
from the cell.  Nitrilotriacetic acid is a tetradentate chelating agent.  The nitrilotriacetic 
acid can therefore form a chelating complex with a nickel ion.   The nickel ion contains a 
coordination sphere able to bind to six different ligands.  Nitrilotriacetic acid  would 
occupy four of these ligand binding sites, leaving two available for interaction with the 
His6 -tag on the protein.26  A drawing of this interaction can be seen in Figure 726.  Ni-
NTA Agarose is composed of Ni-NTA coupled to Sepharose® CL-6B and is able to bind 
approximately 5-10 mg of His6-tagged protein per milliliter of resin.26  A two milliliter 
column bed will be used to purify our proteins.  
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Figure 7. Ni-NTA.  The interaction of two histidine residues located on the protein to the Ni-NTA 
matrix of the column. 
 The first step in the purification of the protein involves the lysis of the cells.  
Once the protein is released from the cell, it can be applied to the Ni-NTA column.  As 
the sample moves through the column, the His6 tagged protein will stick to the column 
bed.  In order to remove proteins of no interest that may have also shown affinity to the 
column bed, a 60 mM imidazole solution will be passed through the column.  Histidine 
contains an imidazole functional group as shown in Figure 8.  The free imidazole will 
displace the binding of nonspecific histidine residues on unwanted protein.  The His6 
tagged protein can then be eluted from the column by further increasing the concentration 
of imidazole to 200 mM.  The imidazole can then be removed from the protein solution 
through buffer exchange.  This will be done by repeat concentration/dilution in an 
Amicon centriprep 3 filtration unit. 
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Figure 8. Histidine versus Imidazole.  A. Imidazole structure. B. Histidine structure. 
 Having purified and concentrated protein allows for its biochemical 
characterization.  Acyl-CoA dehydrogenases have been previously characterized from a 
wide variety of organisms and are responsible for the first, rate limiting step in the β-
oxidation cycle of fatty acid metabolism.27  Also, many of the acyl-CoA dehydrogenases 
are FAD-linked and deliver reducing equivalents to electron transferring flavoproteins 
(ETF).28  Furthermore, Jia Zeng and Ding Li claim that “[A]cyl-CoA dehydrogenases are 
all homotetramers and each subunit contains 1 mol of FAD.27”   
One method of acyl-CoA dehydrogenase activity determination involves the use 
of phenazine methosulfate (PMS) and 2,6-dichlorophenolindophenol (DCPIP).  PMS acts 
as an intermediate electron acceptor and DCPIP act as the terminal electron acceptor for 
the reaction.27  The activity of the enzyme can be monitored spectrophotometrically 
following the decrease in absorbance at 600 nm (ε600 nm = 21 mM-1 cm-1).27  In studies of 
mutated rat mitochondrial acyl-CoA dehydrogenase, activity was assayed in the presence 
of acyl-CoA, phenazine methosulfate (PMS), and 2,6-dichlorophenolindophenol 
(DCPIP).27, 29     
 Another method for acyl-CoA dehydrogenase activity detection is to follow the 
reduction of ferricenium ion at 300 nm (ε300 nm = 4.3 mM-1).30  Ferricenium 
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hexafluorophosphate (Fc+PF6-) is an organometallic oxidant and mimics a number of 
features shown by ETF.28  It can therefore be used as an alternative oxidant of the acyl-
CoA dehydrogenase as it has been used for a number of redox proteins including 
cytochrome C,31 spinach plastocyanin,32 and butyryl-CoA dehydrogenase in Aspergillus 
nidulans.33  In a study of alternate electron acceptors for a medium-chain acyl-CoA 
dehydrogenase purified from pig kidney, Lehman and Thorpe were able to show that 
ferricenium salts are excellent acceptors and can react some 150-fold faster than the 
widely employed phenazine methosulfate.28  The ferricenium ion also avoids the 
necessity of purifying ETF, using mediator dyes, and also exhibits low background 
rates.30  Ferricenium hexafluorophosphate is commercially available and can be 
standardized spectrophotometrically at 617 nm (ε = 410 M-1 cm-1).31 
 Hydroxyacyl-CoA dehydrogenase activity has also been assayed using a variety 
of different methods and conditions.  Hydroxyacyl-CoA dehydrogenases have been 
shown to be either NAD(H) or NADP(H)34 dependent which provides an easy detection 
method of activity.  Upon reduction of NAD(P) to NAD(P)H, there is an increase in 
absorbance at 340 nm (ε = 6.22 mM-1 cm-1).34-36  Although there is an easy detection 
method for the activity of NAD(P) dependent acyl-CoA dehydrogenases, there are a 
variety of other conditions that must be considered when trying to observe enzyme 
activity.  These include the stereospecificity of the enzyme and the pH of the buffer 
system. 
It has been shown that 3-hydroxyacyl-CoA dehydrogenases can be specific 
toward one enantiomer or the other, and in some cases nonspecific.  For example, 
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Alcaligenes eutrophus contains a non-stereospecific Acac-CoA reductase.37  On the other 
hand, Clostridium kluyveri,38 Escherichia coli,39 and Clostridium beijerinckii34 contain 
L(+)-specific 3-hydroxyacyl-CoA dehydrogenases. There are also D(-) specific 3-
hydroxybutyryl-CoA dehydrogenases like those found in pigeon liver40 and Azotobacter 
beijerinckii,41 which are also NADP specific.  If stereospecificity of the substrate is not a 
concern, it is common to follow the reduction of Acac-CoA by monitoring the decrease 
in A340 of NAD(P)H.34, 42, 43  If the stereospecificity is of concern, the stereospecificity of 
the enzyme has been previously determined by comparison to the pig heart enzyme 
which is specific towards the (S)-enantiomer.44,34, 38  Incubating the racemic mixture of 3-
hydroxybutyryl-CoA (HB-CoA) with the pig heart enzyme until there is no activity 
observed removes the (S)-enantiomer.  The pig heart enzyme can then be removed 
through filtration.  Then, by adding the enzyme of interest to the same reaction mixture, it 
can be determined if the enzyme is specific toward the (R)- isomer by monitoring the 
formation of excess NAD(P)H. 
pH plays an important role in enzyme activity and must be considered when 
designing an enzyme assay.  When studying the properties of 3-hydroxybutyryl-CoA 
dehydrogenase from Clostridium beijerinckii, Colby and Chen used 50 mM buffers of 
Na-MES  for pH 5.0 to 6.5, sodium phosphate for pH 6.5 to 8.0, and Tris-Cl  for pH 8.0-
9.0.34  They found that in the HB-CoA forming direction of the reaction, pH of 5.0 
showed maximum activity and decreased as the pH was increased to 8.0 with 
approximately 10 % of activity remaining.  In the Acac-CoA forming direction, 
maximum activity was observed at pH 8.0 for NADP+ and decreased when the pH was 
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both increased and decreased from that value. Similarly, rat mitochondrial his-tagged 
short chain 3-hydroxyacyl-CoA dehydrogenase had optimal activity at pH 5 in 0.1 mM 
phosphate buffer containing 0.1 mM DTT when monitoring the reduction of Acac-CoA.42  
In a study on 3-HB-CoA dehydrogenase in Clostridium kluyveri, there was optimal 
activity at a pH of 6.5 for Acac-CoA reduction with a 14-time slower, but optimal 
oxidation at pH 9.5.38  From these studies, it is clear that the HB-CoA forming reaction is 
optimal in a slightly acidic buffer system and the Acac-CoA forming reaction is optimal 
in a slightly basic buffering system. 
After considering the wide variety of conditions, alternative substrates, and 
activity detection methods, once enzyme activity has been established, the next goal is to 
determine the kinetic rate constants of the MmgB and MmgC reactions.  The rate of a 
chemical reaction is dependent on the concentration of substrate and can be explained by 
the equation45, 46   
 
where enzyme (E) and substrate (S) form an enzyme-substrate complex (ES).  The ES 
then decomposes releasing the product (P) and regenerating the enzyme.  The formation 
of the ES complex is considered to be “fast” and its rate of formation is assumed to be in 
a steady state.46   
The MmgB and MmgC reactions are bisubstrate reactions.  However, we assume 
that the concentration of the oxidizing agent is saturating and does not change 
significantly during the reaction.  Doing so allows us to assume that the catalyzed 
reaction is a first-order process, better called a pseudo-first-order reaction.  Because the 
E + S
k1
k-1
ES E + P,
k2
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reaction is a pseudo-first-order reaction, the above equation allows us to characterize an 
enzyme by calculating its catalytic efficiency (kcat/KM) using Eq 1. and KM.  The catalytic 
efficiency of the enzyme is a measure of the number of catalyzed reactions an enzyme 
makes per unit time.  The maximal velocity (Vmax) can be calculated from Eq. 2. The 
maximal velocity of an enzyme occurs at saturating substrate concentrations, which 
assumes that the enzyme is entirely in ES form.  The Michaelis constant (KM) is 
calculated using Eq. 3.  The Michaelis constant represents the substrate concentration at 
which the reaction is at half of its maximal velocity.  A low KM value describes an 
enzyme that has an increased affinity over a particular substrate than if it had a higher 
value for KM.    
 
  
 
II.B Results and Discussion 
II.B.1 MmgC/B Amplification 
 
  MmgC and mmgB were successfully amplified from the B. subtilis strain 
168 genome by using a polymerase chain reaction (PCR).  The results for mmgC 
amplification are shown by the agarose gel in Figure 9.  The pictures of the agarose gels 
were photographed with a digital camera.  As can be seen in all the pictures of the 
agarose gels experiments, the quality of the image is very low.  For clarity, a box has 
been put around the band of interest.  For mmgC, it can be seen from the gel that the 
amplified gene falls between the 1.0 and 1.2 bp standards.  This is consistent with its 
kcat =
Vmax
[E]T
1. vo =
Vmax[S]
KM + [S]
2.
k-1 + k2
k1
KM =3.Eq.
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expected size of 1134 bps.  The results for mmgB amplification are shown by the agarose 
gel in Figure 10.  The pcr product lies between 0.5 and 1.0 kbs and is consistent with the 
expected gene length of 732 bps.  
 
Figure 9. Agarose Gel of PCR Reaction Product of BS168 Genome.  Lane 1. Standards.  Lane 3.  
PCR reaction product.  The expected size of mmgC is 1134 bps. 
1.0 kb 
1.2 kb 
1.5 kb 
1 3 
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Figure 10. Agarose Gel of PCR Reaction Product of BS168 Genome.  Lane 2. Standards.  Lane 5.  
PCR reaction product.  The expected size of mmgB is 732 bps. 
II.B.2 Cloning MmgC/B 
 
 MmgC and pET-28a were cut with the restriction enzymes XhoI and NdeI.  
Separately, mmgB and pET-28a were cut with XhoI and NcoI.  Then, using T4 DNA 
ligase, mmgC and mmgB were inserted into the vector, pET-28a.  E. coli DH5α cells were 
then transformed using the ligated plasmid, mmgC/pET-28a and mmgB/pET-28a.  
Conclusive results of successful ligation and transformation can be seen in the agarose 
gels in Figure 11 and Figure 12.  Purified plasmids from E. coli DH5α/mmgC/pET-28a 
and  E. coli DH5α/ mmgB/pET-28a cultures were then used to retransform E. coli 
BL21(DE3).   
2 5 
1.0 kb 
0.5 kb 
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Figure 11. PCR Products of Purified Plasmid from mmgC/pET28a/DH5α.  Lanes 3,4,5,6,7,8,9: PCR 
products of the plasmids from transformants.  Lane 12: Molecular weight standards.  Lane 11: PCR 
product of pET28a.  Lane 10: PCR product of BS168 genomic DNA.  The gene length of mmgC  is 
1134 base pairs. 
 
Figure 12. PCR of Purified Plasmid from mmgB/pET28a/DH5α.  Lanes 2,3,4: Plasmids from three 
transformants.  Lane 5: Molecular weight standards.  Lane 6: pET28a.  Lane 7: BS168 genomic 
DNA.  The expected size of mmgB is 732 bps. 
3  4   5  6  7  8   9 101112 
1.0 kb
1.5 kb
2     3     4    5    6    7
1.0 kb
0.5 kb
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II.B.3 MmgC/B Purification 
  
 After successful retransformation into E. coli BL21(DE3), MmgC was purified 
from cultures of BL21(DE3)/MmgC/pET-28a and MmgB was successfully purified from 
cultures of BL21(DE3)/MmgB/pET-28a using nickel nitrilotriacetic acid column 
separation.  Although incubating BL21(DE3)/MmgB/pET-28a at 37 0C overnight 
produced large amounts of protein as observed by SDS-PAGE on whole cell extracts, the 
protein could not be purified due to inclusion body formation. This was observed on 
SDS-PAGE by lack of a corresponding protein band after purification (data not shown).  
In an effort to decrease inclusion body formation and increase the amount of purified 
protein, incubation was conducted at 18 0C.  The expected molecular weight of MmgC 
containing a His6 tag is 41.64 kDa.  The expected molecular weight of MmgB containing 
a His6 tag is 27.85 kDa.  However, this was not consistent with the SDS-PAGE analysis 
(Figure 13) of purified protein for MmgB.  On the gel, MmgB appeared to have a 
molecular weight of about 31 kDa.  Why MmgB did not migrate to its corresponding 
molecular weight position is unclear.  To be sure that the expressed MmgB contained the 
expected sequence of nucleic acids, it was subjected to DNA sequencing, which is 
discussed later.  Using the methods of Bradford47 and bovine serum albumin as standard 
(Figure 14), on average, 2.6 mg of MmgB and 3.8 mg of MmgC was purified per liter of 
culture. 
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Figure 13. SDS-PAGE of Concentrated Protein After Purification.  Lane 3: Molecular weight 
standards.  Lane 4: MmgB.  The expected molecular weight of MmgB containing a 6-Histidine tag is 
27.85 kDA.  Lane 5:  MmgC. The expected molecular weight of MmgC containing a 6-Histidine tag is 
41.64 kDa. 
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Figure 14. Bradford Assay.  Bradford assay using bovine serum albumin as a standard. 
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II.B.4 Determination of Coenzyme Presence in MmgC and MmgB 
 Acyl-CoA dehydrogenases are known as either FAD- or FMN- dependent 
enzymes and the flavins in each have yellow color. When applied to the Ni-NTA column, 
MmgC appeared yellow.  Using MALDI-TOF-MS analysis (Figure 15), it was 
determined that FAD (Figure 16) was the oxidizing agent present in MmgC.   
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Figure 15. MmgC Coenzyme.  MALDI-TOF-MS spectrum of denatured MmgC.  The molecular 
weight of FADH2 is 785.5 a.m.u.  The molecular weight of FMN is 478.4 a.m.u.  
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Figure 16. Flavin Adenine Dinucleotide (FAD).  FAD is composed of adenosine and ribofloavin  
attached together by a pyrophosphoryl group. 
NADP is a common oxidant utilized by 3-hydroxyacyl-CoA dehydrogenases and 
furthermore, 3-hydroxybutyryl-CoA dehydrogenases have been shown to be able to 
utilize either  NAD(H) or NADP(H) as a cosubstrate.34  Using MALDI-TOF-MS 
analysis, it appears that NADP is likely the preferred oxidizing agent found in MmgB 
(Figure 17).  The spectrum contains many unidentified peaks; however, we assume that 
the labeled peaks are representative of the presence of NADP.  
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Figure 17. MmgB Coenzyme.  MALDI-TOF-MS Spectrum of denatured MmgB showing that 
NADPH is present. 
II.B.5  MmgC Activity Analysis 
 
 The purified MmgC was an active enzyme able to convert butyryl-CoA to 
butenoyl-CoA.  The activity was confirmed using MALDI-TOF-MS and HPLC analysis 
as shown in Figure 18 and Figure 19, respectively.  When provided with a different 
substrate, MmgC was also able to convert isobutyryl-CoA to 2-isobutenoyl-CoA, as 
observed by MALDI-TOF-MS.  However, it did not catalyze the reaction of propionyl-
CoA to acrolyl-CoA, or isovaleryl-CoA to 3-methylcrotonyl-CoA.  We also propose that 
MmgC will be able to catalyze the oxidation of 2-methylbutyryl-CoA to 2-
methylbutenoyl-CoA, which will be tested after the complete synthesis and purification 
of this substrate.  The reactions discussed above can be seen in Figure 20. 
 30
8 3 0 8 3 8 8 4 6 8 5 4 8 6 2 8 7 0
M a s s  ( m / z )
6 5 5 . 3
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
%
 I
n
te
n
s
it
y
4 7 0 0  R e fle c to r  S p e c  # 1 [B P  =  8 6 0 .0 ,  6 5 5 ]
8
6
0
.0
3
8
3
8
3
8
.0
7
3
3
8 3 0 8 3 8 8 4 6 8 5 4 8 6 2 8 7 0
M a s s  (m / z )
3 2 5 . 5
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
%
 I
n
te
n
s
it
y
4 7 0 0  R e fle c to r  S p e c  # 1 [B P  =  8 5 8 .0 ,  3 2 5 ]
8
5
8
.0
3
7
8
8
6
0
.0
3
9
2
8
3
6
.0
7
2
6
8
3
8
.0
8
2
5
Butyryl-CoA + H+
Butyryl-CoA + Na+ 
Butenoyl-CoA + H+ 
Butenoyl-CoA + Na+ 
Butyryl-CoA + H+
Butyryl-CoA + Na+ 
A. 
B. 
g 
g 
 
Figure 18. MmgC/Butyryl-CoA Reaction.  MALDI-TOF-MS spectra of the MmgC reactions.  All 
peaks are labeled in atomic mass units. A) Reaction mixture lacking MmgC.  B)  Reaction mixture 
including MmgC.  
Ferrocenium
Butenoyl-CoA
Butyryl-CoA
 
Figure 19. HPLC of MmgC/Butyryl-CoA Reaction.  Top: 450 µM Ferricenium Hexafluorophosphate, 
200 µM Butyryl-CoA, 200 µM Butenoyl-CoA.  Middle: Ferricenium, Butyryl-CoA, and MmgC after 
an initial incubation of 20 minutes.  Bottom: Ferricenium, Butyryl-CoA, and MmgC after an 
incubation time of 2 hours.  
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Figure 20. Proposed MmgC Reactions.  MmgC represents an observed reaction.  An X represents a 
reaction that was not observed.  A ? denotes a reaction not studied. 
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II.B.6 MmgC Kinetic Analysis 
 
 MmgC has shown activity against both butyryl-CoA and isobutyryl-CoA.  Kinetic 
analysis of the mmgC reactions have an apparent kcat for MmgC against butyryl-CoA to 
be 6.3 x 10-2 s-1 with a kcat/ KM value of 4.5 x 102 M-1s-1   The apparent kcat for MmgC 
against isobutyryl-CoA was calculated to be 1.1 x 10-1 sec-1 with a kcat/ KM of 1.1 x 103   
M-1s-1. The Michaelis-Menten plot of the reactions can be seen in Figure 21.  
 
Figure 21. MmgC Kinetic Plot.  Michaelis-Menten Plot of MmgC Reactions. 
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II.B.7 MmgB Kinetic Analysis 
 MmgB did not catalyze the conversion of DL-β-hydroxybutyryl-CoA, D-β-
hydroxybutyryl-CoA, or L-β-hydroxybutyryl-CoA to acetoactetyl-CoA.  In the event that 
pH or buffer salts were inhibiting enzyme activity, several different buffer systems were 
tried; none of which proved adequate for enzyme activity.  Furthermore, because NADP+ 
and NAD+ can both act as electron acceptors for β-hydroxyacyl-CoA oxidation, both 
coenzymes were provided in reaction mixtures; neither of which proved adequate to 
increase enzyme activity.  Likewise, MmgB did not catalyze the conversion of 
acetoacetyl-CoA to 3-hydroxybutyryl-CoA with either NADH or NADPH provided as 
coenzyme. 
With the possibility of acetoacetyl-CoA exhibiting feedback inhibition towards 
MmgB, a reaction mixture was also made in the presence of MmgA.  MmgA is a 
thiolase,15 and would reduce the concentration of acetoacetyl-CoA as it is converted to 
acetyl-CoA.  However, neither acetyl-CoA nor acetoacetyl-CoA formation was observed 
by MALDI-TOF-MS analysis. 
In case of isomer inhibition, enantiopure (R)- and (S)- β-hydroxybutyryl-
coenzyme A was synthesized.  Neither substrate was converted into the expected product, 
as observed by MALDI-TOF-MS analysis. 
II.B.8 (S)- and (R)-β-Hydroxybutyryl-CoenzymeA Synthesis 
 Yuan, et al, had previously synthesized (R)-3-hydroxybutyryl CoA.48  By 
following their work with a few minor differences, (S)- and (R)-β-hydroxybutyryl-
coenzyme A were successfully synthesized.  Because the starting material, β-
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hydroxybutyric acid, was enantiopure, it was assumed that our product was also enantio-
pure.  In order to undoubtedly conclude that the synthesized substrates were, in fact, 
enantiopure, polarimetry experiments are needed.  Although they were attempted, the 
purified samples were too dilute to make any conclusion on the enantiopurity.  In order to 
increase the concentration of the sample, larger quantities of reactants would be needed 
and in an effort to lower expenditures, small amounts of coenzyme A were used.  
However, if MmgB had shown activity toward an enantiopure substrate, the experiment 
would have been scaled up in order to prove enantiopurity.  The synthesized product was 
purified using reverse phase HPLC and lyophilization.  In order to conclude that β-
hydroxybutyryl-coenzyme A had been synthesized, MALDI-TOF-MS analysis was 
performed. MALDI-TOF-MS analysis showed the presence of an 854 a.m.u analyte 
(Figure 22), presumably our product.   
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Figure 22. MALDI-TOF-MS analysis of the synthesized (S)- and (R)- 3-HB-CoAs.  The top spectrum 
is the (S)-isomer.  The bottom spectrum is the (R)-isomer.  The expected mass of 3-HB-CoA is 853.6 
a.m.u. 
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II.B.9  MmgB Gene Sequencing 
 The sequence of MmgB, analyzed by SeqWright DNA Technology Services, 
Houston, TX was returned and matched the DNA sequence published by Bryan, et al.13  
However, when aligned with the Subtilist genome project data,24 there were three 
nucleotides present that do not match the data published by Bryan, et al, (Figure 23).  The 
MmgB sequence published by Bryan, et al, can be found in the NCBI data bank under 
accession number U29084.  The Subtilist genome project lacks a guanine at positions 499 
and 504, and also a cytosine at position 505.  Although there are differences between the 
two sequences, the returned sequence was properly in frame with the promoter.  
However, because the nucleic acids are not located consecutively within the sequence, 
there is a total difference of three amino acids (Figure 24).  According to the Subtilist 
genome project, the expressed mmgB protein has an arginine residue at position 166 and 
a threonine residue at positon 167.  However, in the work published by Bryan, et al, and 
also the sequence returned to us by SeqWright DNA Technology Servicess, there should 
be an alanine residue located at position 166, a lysine residue located at position 167, and 
the extra amino acid, proline, located at position 168.  Although there are differences 
between the two sequences, the gene is transcribed correctly into RNA resulting in a 
complete, correct translation into protein.   
 The sequence of mmgB is not attributed to its inactivity, because the nucleic acid 
sequence is still in frame with the promoter.  However, there is still the possibility that 
the His6 tag located on the C-terminus of the protein may be interfering with its activity.  
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MmgB Sequence Alignment
1 t t g a a a c g g c t g a a g a a a c a g c t g g c c c g t g a t g c t g a g a a a g g a a a a a g
1 T T G A A A C G G C T G A A G A A A C A G C T G G C C C G T G A T G C T G A G A A A G G A A A A A G
51 g a c c g a g a c g g a a g t g a a g a g c g t a a t c a a c c g c a t t t c g a t t t c t c a a a
51 G A C C G A G A C G G A A G T G A A G A G C G T A A T C A A C C G C A T T T C G A T T T C T C A A A
101 c a c t t g a g g a g g c a g a g c a t g c g g a c a t t g t g a t t g a g g c t a t c g c a g a a
101 C A C T T G A G G A G G C A G A G C A T G C G G A C A T T G T G A T T G A G G C T A T C G C A G A A
151 a a c a t g g c g g c a a a a a c t g a g a t g t t t a a a a c a c t t g a t c g c a t t t g c c c
151 A A C A T G G C G G C A A A A A C T G A G A T G T T T A A A A C A C T T G A T C G C A T T T G C C C
201 g c c t c a t a c g a t t t t g g c c a g c a a t a c a t c t t c c t t g c c t a t t a c a g a a a
201 G C C T C A T A C G A T T T T G G C C A G C A A T A C A T C T T C C T T G C C T A T T A C A G A A A
251 t c g c t g c t g t a a c a a a c c g g c c t c a a c g g g t t a t t g g c a t g c a t t t t a t g
251 T C G C T G C T G T A A C A A A C C G G C C T C A A C G G G T T A T T G G C A T G C A T T T T A T G
301 a a t c c c g t c c c t g t a a t g a a g c t g g t a g a a g t g a t t c g a g g c t t g g c t a c
301 A A T C C C G T C C C T G T A A T G A A G C T G G T A G A A G T G A T T C G A G G C T T G G C T A C
351 a t c a g a a g a a a c g g c c t t a g a t g t t a t g g c a t t a g c g g a a a a g a t g g g g a
351 A T C A G A A G A A A C G G C C T T A G A T G T T A T G G C A T T A G C G G A A A A G A T G G G G A
401 a a a c a g c g g t a g a a g t c a a t g a t t t t c c t g g g t t t g t t t c c a a c c g t g t g
401 A A A C A G C G G T A G A A G T C A A T G A T T T T C C T G G G T T T G T T T C C A A C C G T G T G
451 c t t c t t c c a a t g a t t a a t g a a g c c a t c t a t t g c g t g t a t g a g g g a g t g - c
451 C T T C T T C C A A T G A T T A A T G A A G C C A T C T A T T G C G T G T A T G A G G G A G T G G C
500 g a a - - c g g a g g c a a t a g a t g a a g t g a t g a a g c t g g g c a t g a a t c a t c c g a
501 G A A G C C G G A G G C A A T A G A T G A A G T G A T G A A G C T G G G C A T G A A T C A T C C G A
548 t g g g t c c g c t t g c a t t a g c g g a t t t t a t c g g a c t g g a t a c g t g t t t a t c a
551 T G G G T C C G C T T G C A T T A G C G G A T T T T A T C G G A C T G G A T A C G T G T T T A T C A
598 a t t a t g g a a g t c c t t c a c t c a g g c c t t g g c g a t t c c a a a t a c c g t c c t t g
601 A T T A T G G A A G T C C T T C A C T C A G G C C T T G G C G A T T C C A A A T A C C G T C C T T G
648 c c c g c t g c t c c g c a a g t a t g t c a a a g c a g g c t g g c t t g g c a a a a a g a g c g
651 C C C G C T G C T C C G C A A G T A T G T C A A A G C A G G C T G G C T T G G C A A A A A G A G C G
698 g a c g c g g t t t t t a t g a c t a t g a g g a g a a g a c t t c c
701 G A C G C G G T T T T T A T G A C T A T G A G G A G A A G A C T T C C
 
Figure 23. DNA sequence alignment of the mmgB gene.  The lower case sequence is from the Subtilist 
web server.  The upper-case sequence is from the NCBI data bank, accession number U29084. 
MmgB Amino Acid Alignment
NCBI 1 K R L K K Q L A R D A E K G K R T E T E V K S V I N R I S I S Q T L E E A E H A D I V I E A I A E N
Subt ilist 1 K R L K K Q L A R D A E K G K R T E T E V K S V I N R I S I S Q T L E E A E H A D I V I E A I A E N
NCBI 51 M A A K T E M F K T L D R I C P P H T I L A S N T S S L P I T E I A A V T N R P Q R V I G M H F M N
Subt ilist 51 M A A K T E M F K T L D R I C P P H T I L A S N T S S L P I T E I A A V T N R P Q R V I G M H F M N
NCBI 101 P V P V M K L V E V I R G L A T S E E T A L D V M A L A E K M G K T A V E V N D F P G F V S N R V L
Subt ilist 101 P V P V M K L V E V I R G L A T S E E T A L D V M A L A E K M G K T A V E V N D F P G F V S N R V L
NCBI 151 L P M I N E A I Y C V Y E G V A K P - - E A I D E V M K L G M N H P M G P L A L A D F I G L D T C L
Subt ilist 151 L P M I N E A I Y C V Y E G V - - - R T E A I D E V M K L G M N H P M G P L A L A D F I G L D T C L
NCBI 199 S I M E V L H S G L G D S K Y R P C P L L R K Y V K A G W L G K K S G R G F Y D Y E E K T S
Subt ilist 198 S I M E V L H S G L G D S K Y R P C P L L R K Y V K A G W L G K K S G R G F Y D Y E E K T S
 
Figure 24. Amino Acid Alignment.  The amino acid alignment of MmgB from NCBI accession 
number U29084 and the Subtilist web server. 
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II.C Experimental Section 
II.C.1  MmgC/B Amplification 
 
To isolate B. subtilis 168 DNA, BS168 cells were streaked onto an LB plate and 
incubated overnight at 37 0C.  A starter culture was then made by inoculating 5 mL of LB 
with one colony of BS168.  The Wizard® Genomic DNA Purification Kit, manufactured 
by Promega, was then used to isolate the BS168 genomic DNA.  In order to amplify the 
genes of interest, primers were designed for the mmgC and mmgB gene.  
 The upstream primer designed for mmgC was 5’-GGG GTG GCC CAT ATG 
CAT GTA AC- 3’ (NdeI restriction site) and the downstream primer was 5’- CGT TTT 
TCT CGA GTC AGG TTC CGC -3’ (XhoI restriction site).  For mmgB, the upstream 
primer was 5’-GCA GCC ATG GAA CGG CTG AAG- 3’ (NcoI restriction site) and the 
downstream primer was 5’- AAT AGC TCG AGG GAA GTC TTC TCC TCA TAG -3’ 
(XhoI restriction site).  The primers were manufactured by Integrated DNA Technologies, 
Coralville, IA.  A high-fidelity polymerase chain reaction (PCR) kit, manufactured by 
Finnzymes Oy, was then used to amplify mmgC/B in a thermocycler.  The reaction was 
started with an initial incubation at 98.0 0C for 30 seconds, followed by 30 cycles of 
denaturing at 98.0 0C for 10 seconds, annealing for 30 seconds at 63.4 0C for mmgC and 
63.0 for mmgB, and extension at 72.0 0C for 30 seconds.  After thirty cycles the reaction 
mixture was held constant at 4.0 0C. 
In order to determine that the polymerase chain reaction (PCR) amplification was 
successful, the PCR products were analyzed by 0.7 % agarose gel electrophoresis.  The 
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QIAquick PCR Purification Kit, manufactured by QIAGEN (cat no. 28104) was then 
used to purify the PCR products.  
II.C.2 MmgC/B Cloning 
The QIAprep® Spin Miniprep Kit, manufactured by QIAGEN Sciences, was used 
to purify pET-28a plasmid from transformed DH5α/pET28a cells.  A restriction digest 
was then performed on the PCR products and purified pET28a plasmid. The restriction 
enzymes XhoI and NdeI were used for mmgC and pET28a.  The restriction enzymes XhoI 
and NcoI were used for mmgB and pET28a.  The restriction enzymes were manufactured 
by New England BioLabs.  A low temperature agarose gel was then used to separate the 
components of the reaction mixture.  The desired fragments (mmgC/B and pET28a 
containing) were then cut from the gel and melted at 75 0C.  The genes were then ligated 
into the pET28a vector with  T4 DNA ligase in a thermocycler.  The ligation reaction 
temperatures were set at 37.0 0C for 30 minutes, then 23.0 0C for 2 hours 30 minutes, and 
finally held at 16.0 0C overnight. 
After successful ligation of the mmgC/pET-28a and mmgB/pET-28a systems, 
DH5α cells were transformed with the ligated products.  The transformed cells were then 
plated onto agar containing kanamycin (30 mg/L) and incubated overnight at 37 0C.  
Each resulting colony was then used to inoculate 5 mL of LB containing kanamycin (30 
mg/L).  The plasmids from these colonies were purified and a PCR reaction was run on 
each sample.   
 Having successfully ligated the genes of interest with pET28a expression vectors, 
the mmgC/pET-28a and mmgB/pET-28a expression vectors needed to be introduced into 
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an appropriate expression host.  To do that, E. coli cells, of the strain BL21(DE3), were 
swabbed onto a Luria-Burtani (LB) plate.  The plate was then incubated overnight at 37 
0C.  The cells from one colony were then added to 5 mL of LB and grown overnight at 37 
0C.  Two hundred micro-liters of this cell culture was then added to 5 mL of LB.  The 
sample was shaken until cloudy and then subjected to centrifugation at top speed in a 
clinical centrifuge.  The supernatant was discarded and the remaining cells were 
resuspended in 3 mL of cold 50 mM CaCl2 and vortexed briefly.  The resuspension was 
incubated in ice for 30 minutes.  The sample was then centrifuged for 5 minutes at top 
speed in a clinical centrifuge and the supernatant was discarded.  The cellular pellet was 
then resuspended in 1 mL of cold CaCl2 (50 mM).  One hundred micro-liters of 
competent cells were then mixed with 1 µL of suspended plasmid and incubated on ice 
for 30 minutes.  The sample was then incubated at 37 0C for 2 minutes and then at room 
temperature for 10 minutes.  One milliliter of LB was then added to the sample and 
incubated at 37 0C for 1 hour.  The sample was spun at 8,000 rpm for 5 minutes and 1 mL 
of the supernatant was discarded.  The pelleted cells were resuspended and plated onto 
agar plates containing 30 µg/mL kanamycin and incubated overnight at 37 0C.  
II.C.3 MmgC/B Overexpression and Purification 
One starter culture was made by inoculating 5 mL of LB containing 30 µg/mL 
kanamycin with one colony of mmgB/pET28a/BL21(DE3) and 
mmgC/pET28a/BL21(DE3), separately.  The cultures were incubated overnight at 37 0C. 
Two milliliters of the starter culture were then used to inoculate 1 L of LB containing 30 
µg/mL kanamycin and allowed to grow at 37 0C until their optical density at 595 nm 
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(OD595) reached 0.5, (OD595  = 0.5).  Isopropyl-ß-D-thiogalactopyranoside (IPTG) was 
then added to a final concentration of 1 mM in order to induce mmgC/B production.  The 
mmgC/pET28a/BL21(DE3) culture was incubated overnight at 37 0C and the 
mmgB/pET28a/BL21(DE3) was incubated overnight at 18 0C.  During growth, samples 
were collected every hour for three hours and once after an overnight incubation.  A 10 % 
SDS gel was run to check for increased protein concentration as a function of incubation 
time. 
The cells from the overnight cultures were harvested by centrifugation (6000 g, 
10 minutes.)  The cells were then resuspended in binding buffer (5 mM imidazole, 500 
mM NaCl, 20 mM Tris·HCl, pH 7.9) and lysed by sonication on ice for 3 minutes.  The 
lysate was cleared by centrifugation (11000 g, 30 minutes.)  The lysate was then syringe 
filtered through a 0.45 micron syringe filter (Corning®) and applied to a nickel-
nitrilotriacetic acid (Ni-NTA) column.  Proteins without the His6-tag were removed using 
wash buffer (60 mM imidazole, 500 mM NaCl, 20 mM Tris·HCl, pH 7.9) and MmgC/B 
was eluted from the column with elution buffer (200 mM imidazole, 500 mM NaCl, 20 
mM Tris·HCl, pH 7.9).  The methods of Bradford were then used to determine the 
amount of purified protein from each sample.47  The MmgC/B eluent was subject to 
buffer exchange by repeated dilution/concentration cycles with 50 mM Tris·HCl, 20 mM 
Mg2Cl at pH 8.0.  MmgC/B was concentrated using Amicon centriprep 3 filtration units.  
SDS-PAGE was run on the concentrated samples to check for purity and integrity.  
Glycerol was then added to the protein sample to a final concentration of 10 % and the 
protein was stored at -80 0C.   
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II.C.4  Matrix Assisted Laser Desorption Ionization - Time of Flight -  
    Mass Spectrometry 
Matrix assisted laser desorption ionization – time of flight – mass spectrometry 
(MALDI-TOF-MS) was used in the analysis of CoA and its derivatives and also for the 
analysis of coenzyme presence in the purified protein.  The MALDI-TOF-MS instrument 
used was a 4700 Proteomic Analyzer, made by Applied Biosystems.  The samples were 
analyzed using MS reflector positive ion mode with a fixed laser intensity of 3751.   
The sample matrix consisted of 10 mg of 2,5-dihydroxybenzoic acid dissolved in 
1 mL of matrix A diluent (50 % acetonitrile in 0.3 % trifluoroacetic acid.)  Unless 
otherwise noted, all samples were prepared by making a 50:50 mixture of sample:matrix, 
where 0.5 µL was spotted onto the sample plate and allowed to air dry.    
II.C.5 Determination of Coenzyme Presence in MmgC and MmgB 
Previous MmgB and MmgC samples that had precipitated out of solution were 
subject to MALDI-TOF-MS analysis in order to determine if any coenzyme may have 
coeluted during purification.  Also, 290 µM samples of FAD(H), FMN, NAD(H), and 
NADP(H) were ran individually as standards. 
II.C.6 MmgC Activity Determination 
A reaction mixture was made containing 1.5 mM phenazine methosulfate (PMS), 
48 uM 2,6-dichloroindophenol (DCPIP), 33 uM butyryl-CoA, and MmgC.  Product 
formation was monitored using MALDI-TOF analysis.  High performance liquid 
chromatography (HPLC) was also used to confirm product formation.  A Varian Prostar 
HPLC instrument equipped with a 150 x 3.9 mm Waters NovaPak C18 reversed phase 
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column with a 4 µM particle size was used.  An isocratic method of 95% of 200 mM 
ammonium actetate, pH 6.0, and 5% acetonitrile was run at 1 mL/min and the absorbance 
was monitored at 261 nm.  However, PMS and the CoA derivatives being studied had 
similar retention times.  In order to avoid the interfering peak caused by PMS, 
ferricenium hexafluorophosphate (Fc+PF6-) ion was used as the terminal electron acceptor 
for the reaction and replaced both DCPIP and PMS.30  Fresh ferricenium 
hexafluorophosphate solution was prepared by dissolving the salt in 10mM HCl and 
standardizing it spectrophotometrically at 617 nm using 617 M-1cm-1 as the extinction 
coefficient.31  The modified MmgC reaction mixture contained 200 µM butyryl-CoA, 450 
µM ferricenium hexafluorophosphate, and 6.94 µM MmgC.  A fresh solution of this 
reaction mixture was analyzed using HPLC under the same conditions described above.  
II.C.7 MmgC Kinetic Analysis 
Reactions were prepared with 500 µM Fc+PF6-, 50 µM MmgC, and varying 
concentrations of butyryl-CoA. The reaction mixture was brought to 500 µL using 50 
mM Tris / 20 mM MgCl2 buffer at a pH = 8.  MmgC activity was followed by the 
decrease in absorbance at 300 nm as the ferricenium ion (Δε = 4300 M-1cm-1)30 was 
reduced.  The reaction was monitored using a CARY 100 BIO, UV-visible 
spectrophotometer set at a wavelength of 300 nm. 
 The substrate tolerance of MmgC to propionyl-CoA, isobutyryl-CoA, and 
isovaleryl-CoA was monitored by looking for product formation using MALDI-TOF-MS.  
Reaction mixtures were made in 50 mM Tris / 20 mM MgCl2 buffer at a pH = 8 and 
contained 500 µM Fc+PF6-, 68 µM MmgC and 290 µM acyl-Coenzyme A derivative.   
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II.C.8  MmgB Activity Determination 
Reaction mixtures were made containing 290 µM NAD+, 290 µM D, L-3-
hydroxybutyryl-CoA and MmgB in the buffers listed in Table 1.  MALDI-TOF-MS 
analysis was used to observe product formation.  
 
Table 1.  MmgB Buffers 
MmgB Reaction Buffers 
Buffer pH 
50 mM Tris 9 
100 mM KPi (Potassium Phosphate) 6 
100 mM KPi 6.4 
100 mM KPi 7 
100 mM KPi 7.4 
100 mM KPi 8 
50 mM Tris / 150 mM KCl 6 
50 mM Tris / 150 mM KCl 8 
50 mM Tris / 150 mM KCl 9 
50 mM Tris / 20 mM MgCl2 8 
 
Two different reaction mixtures were also made and analyzed using MALDI-
TOF-MS after a 1 hour incubation at room temperature and after a 7 hour incubation at 
room temperature.  The first contained 200 µM HB-CoA, 200 uM NADPH, and MmgB 
in 50 mM Tris / 20 mM MgCl2 at pH = 8.0 buffer.  The second reaction mixture was 
made to contain 200 uM Acac-CoA, 200 uM NADP+, and MmgB in 50 mM Tris / 20 
mM MgCl2 at pH = 8.0 buffer.   
In case of isomer inhibition, analysis of reactions containing enantiopure substrate 
was also performed.  In 50 mM potassium phosphate buffer (pH 6 and 7) and in 50 mM 
Tris buffer (pH 8 and 9), 4.8 µL of MmgB, 200 µM NADP+, and 2 µL of enantiopure 
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substrate (concentration unknown) was added.  After a 30 minute incubation at room 
temperature the samples were subjected to MALDI-TOF-MS analysis.   
In 100 µL of Tris buffer (pH = 9), 10 µL of MmgB, 10 uL of enantiopure HB-
CoA, and either 200 µM NADP+ or NAD+ was added.  After a 30 minute and overnight 
incubation at room temperature, the samples were subjected to MALDI-TOF-MS 
analysis. 
II.C.9 MmgB Sequencing 
 pET28a/mmgB plasmid was purified from host BL21(DE3) cells using the 
QIAquick MiniPrep Kit, manufactured by QIAGEN.  The plasmid was then 
retransformed into DH5α using previously described methods.  Plasmid was then purified 
from an overnight culture of mmgB/DH5α using the QIAquick MiniPrep Kit.  The 
plasmid was diluted to 250 µg/mL and sent to SeqWright DNA Technology Services, 
Houston, TX for sequencing.   
II.C.10 (S)- and (R)-β-Hydroxybutyryl-CoenzymeA Synthesis 
 (S)- and (R)-β-hydroxybutyryl-coenzymeA (HB-CoA) synthesis was done 
following the work of Yuan, et al.48  The enantiopure synthesis of (S) and (R)-β-
hydroxybutyryl-CoA was carried out separately using the same procedure. To 4 mL of 
dry dimethlyformamide (DMF), 1.3 g of tert-butyldimethyl silyl chloride (TBDMSCl) 
was added.  Under argon and on ice, 1.7 grams of imidazole was added and dissolved.  
Two hundred fifty milligrams of enantio-pure β-hydroxybutyric acid (Sigma) was 
dissolved in 1 mL of dry DMF and added to the reaction.  The reaction was warmed to 
room temperature and stirred overnight.  The mixture was poured over 30 mL of 
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saturated NaCl and extracted with a 1:3 mixture of ether:petroleum ether (5 x 15 mL).  
The mixture was dried over MgSO4, filtered, and the filtrate was concentrated under 
reduced pressure.  The residue was dissolved in 30 mL methanol and 15 mL THF.  Seven 
hundred fifty milligrams potassium carbonate dissolved in 5 mL water was added and the 
reaction was stirred overnight at room temperature.  To the reaction, 10 mL of saturated 
NaCl was added and the pH was adjusted to 3 with 1 M H2SO4.  The solution was then 
extracted (5 x 10 mL) with a 1:3 ether: petroleum ether mixture.  The organic layers were 
combined, dried over MgSO4, and filtered.  The solvent was removed under reduced 
pressure overnight.  The remaining residue was dissolved in 5 mL of CH2Cl2.  Under 
argon, at 0 0C, 1 equivalent of dicyclohexylcarbodiimide (DCC) and 1 equivalent of 
benzenethiol was added, warmed to room temperature, and stirred overnight.  Fifteen 
milliliters of ether was added and the precipitate was removed by filtration.  The solvent 
was removed under reduced pressure.  The residue was then purified by flash 
chromatography (5% ethyl acetate in hexanes) and the solvent was removed under 
reduced pressure.  The remaining residue was dissolved in 2 mL of acetonitrile and 5 mL 
of 5% HF in acetonitrile was added.  When the reaction ceased, as monitored by thin 
layer chromatography (TLC), saturated NaHCO3 was added until the evolution of CO2 
ceased.  The mixture was then extracted with ether (3 x 20 mL).  The organic layers were 
combined, washed with NaCl, and dried over MgSO4.  The solvent was removed under 
reduced pressure.  To 0.250 mL of a 50 mM solution of potassium phosphate buffer,    
pH = 7.8, saturated with argon, 10 mg of CoA dissolve in 100 µL acetonitrile was added.  
The reaction was stirred vigorously overnight.  One hundred microliters of water was 
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added and the mixture was extracted with ether (5 x 3 mL).  The aqueous layer was 
further purified with HPLC.  For HPLC, one hundred microliters of the sample was 
dissolved in 100 µL of 95% ammonium acetate buffer (pH 6.5) and 5% acetonitrile.  The 
sample was syringe filtered (45 µm) and HPLC was run isocratically with 95% 
ammonium acetate buffer, pH 6.5, and 5% acetonitrile.  The peaks from five 10 µL 
injections of sample from above were collected and pooled.  The collected sample was 
lyophilized, diluted with 2 mL water and lyophilized again to remove ammonium acetate.  
MALDI-TOF-MS analysis was run on each sample. 
II.D Conclusion 
 MmgC and MmgB from Bacillus subtilis strain 168 were successfully cloned into 
pET-28a plasmid and transformed into E. coli strain BL21(DE3).  IPTG was successfully 
used to induce MmgC/B transcription and translation.  Because of the C-terminal His6-
tag attached from its insertion into pET-28a, MmgC was purified using a Ni-NTA 
column.  Likewise, an N-terminal His6-tag on MmgB allowed for its purification using a 
Ni-NTA column. 
 MALDI-TOF-MS analysis confirmed that FAD was present in MmgC and NADP 
in MmgB.  Because of their presence, it is presumed that they are coenzymes and act as 
the oxidizing agents for the catalyzed reactions. 
 The activity of MmgC was determined spectrophotometrically by HPLC and 
MALDI-TOF-MS analysis.  During HPLC, the presence of the coenzyme A derivative 
used in the assay was monitored at 261 nm.  Using butyryl-CoA and butenoyl-CoA as 
standards for the determination of the retention times of reactants and products, it was 
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confirmed that the purified protein was, in fact, active and able to catalyze the conversion 
of butyryl-CoA to butenoyl-CoA.  This reaction was also confirmed using MALDI-TOF-
MS analysis using the same standards and under the same reaction conditions. 
 The activity and also the selectivity of MmgC have been confirmed by HPLC and 
MALDI-TOF-MS analysis towards butyryl-, isobutyryl-, propionyl-, and isovalyryl-CoA.  
MmgC is able to catalyze the conversion of butyryl-CoA to butenoyl-CoA and 
isobutyryl-CoA to isobutenoyl-CoA.  On the other hand, MmgC was not able to catalyze 
the conversion of propionyl-CoA to acrolyl-CoA or isovaleryl-CoA to 3-methylcrotonyl-
CoA. 
 This is consistent with the expected metabolic pathway involving MmgC.  
Butenoyl-CoA can be further broken down into acetyl-CoA by the rest of the enzymes in 
the β-oxidation pathway of fatty acid metabolism.  The resulting isobutenoyl-CoA, from 
isobutyryl-CoA, can be further metabolized into acetyl-CoA and propionyl-CoA.  
Propionyl-CoA can then enter the methylcitric aid cycle.  The fact that propionyl-CoA 
would enter the methylcitric acid cycle explains why it is not likely oxidized by MmgC to 
produce acrolyl-CoA.  If isovaleryl-CoA were oxidized by MmgC, the product would be 
3-methylcrotonyl-CoA.  If 3-methylcrotonyl-CoA were to follow the pathway of β-
oxidation, the next step would be hydration across the double bond at position three.  
However, oxidation cannot occur on a tertiary alcohol.  Therefore, this substrate is not 
suitable for the β-oxidation pathway. 
 One other substrate that can logically be broken down through the β-oxidation 
pathway is 2-methylbutyryl-CoA; the expected penultimate product of anteiso fatty acid 
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β-oxidation.  The resulting product from the MmgC reaction would be 2-methylbutenoyl-
CoA which would ultimately be degraded into acetyl-CoA and propionyl-CoA.  
However, this reaction was not studied because this substrate is not commercially 
available.  For a later study of this reaction, the synthesis of 2-methylbutyryl-CoA is 
being attempted by another colleague, Hussam Hamoush, following a modified procedure 
of the HB-CoA synthesis described earlier.   
 Monitoring the reduction of the ferricenium ion during catalysis, the kinetic rate 
constants, Km, Vmax, and kcat were calculated for MmgC.  The calculated values show that 
MmgC prefers isobutyryl-CoA over butyryl-CoA as substrate.  As determined by the 
kcat/KM value, MmgC is about 2.5 fold more efficient at catalyzing the reaction of 
isobutyryl-CoA to isobutenoyl-CoA than it is at catalyzing the reaction of butyryl-CoA to 
butenoyl-CoA.  Because the membranes of B. subtilis contain a significant amount of 
branched chain fatty acids in the form of phospholipids and that it can be proposed that B. 
subtilis is metabolizing these phospholipids for the generation of energy during 
sporulation, it makes sense that there would be an acyl-CoA dehydrogenase that shows a 
higher specificity toward branched chains.   
 MmgC is an enzyme that can catalyze the oxidation of an acyl-CoA to form an 
enoyl-CoA.  This is particularly important when B. subtilis is undergoing sporulation and 
in need of energy.  During the catalytic conversion of reactant to product, one equivalent 
of FADH2 is also produced.  The electrons given to FAD to produce FADH2 are 
subsequently used for the production of two ATP molecules.  The newly synthesized 
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enoyl-CoA continues through the pathway of the β-oxidation of fatty acid metabolism 
producing more energy for the sporulating B. subtilis.   
 The gene yngF, also controlled by σE, shows sequence similarity to 3-
hydroxybutyryl-CoA dehydratase and may be responsible for the hydration of the enoyl-
CoA to produce a β-hydroxyacyl-CoA.24    If this is true, this gene could be responsible 
for the next step in the β-oxidation of fatty acids.  Currently, this hypothesis is being 
tested by Jeffrey Smith at The University of North Carolina at Greensboro. 
Although not confirmed in this study, MmgB may then be responsible for the 
dehydrogenation of the β-hydroxyacyl-CoA to form acetoacetyl-CoA.  However, MmgB  
showed no catalytic activity towards D- or L-β- hydroxybutyryl-CoA.  Although there is 
conflict between the amino acid sequences from Bryan, et al, and the Subtilist genome 
project, the differences do not appear to be significant enough to affect the activity of the 
enzyme.  Therefore, the lack of activity for this enzyme must be further investigated to 
gain full understanding of the role of this gene during sporulation. 
Two hypotheses as to why there is no observed activity can be argued.  The first 
hypothesis is that the presence of the C-terminal histidine-tag on MmgB may be 
interfering with its activity. The second hypothesis is that 3-hydroxybutyryl-CoA may not 
be the correct substrate for MmgB.   
In order to test whether the His6-tag is interfering with activity, the histidine-tag 
can be moved from the C-terminus to the N-terminus of the polypeptide sequence.  In 
order to do this, new primers could be designed to incorporate NdeI and XhoI restriction 
sites.  This will allow for the cloning into the pET28a vector with the histidine-tag 
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located at the 5’ end of the DNA sequence.  Furthermore, because the pET28a vector 
contains a thrombin recognition site directly upstream from the NdeI restriction site 
(Figure 2549), the histidine-tag could be removed upon treatment with thrombin.  
 
Figure 25. pET-28a(+) Vector Map    
 Based on the operon in which mmgB is located and the data already collected for 
MmgA15 and MmgC, it does not seem plausible that 3-hydroxybutyryl-CoA would not be 
recognized by MmgB.  However, if the relocation and/or removal of the histidine-tag 
does not show activity, alternative substrates could be used to test for enzyme activity.  In 
order to test the hypothesis that 3-hydroxybutyryl-CoA is the wrong substrate, different 
substrates could be used, including, but not limited to, substrates of longer chain length 
and branched substrates.  The new substrates could include a medium and long chain 3-
hydroxyacyl-CoA and also methyl-branched 3-hydroxyacyl-CoAs. These substrates are 
not commercially available and would need to be synthesized.   
Once the activity of MmgB has been established, its kinetic parameters, Km and 
Vmax could be measured by following an increase in absorbance at 340 nm as NAD(P)+ is 
reduced to NAD(P)H.   After Km and Vmax have been determined, MmgB’s specificity for 
different substrates could be determined.  Also, size exclusion chromatography could be 
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used to determine if any protein-protein complex formation is occurring between 
different Mmg proteins. 
 Biochemically characterizing mmgC as an acyl-CoA dehydrogenase has provided 
one more piece of information that allows for the understanding of energy production in 
sporulating B. subtilis.  Likewise, it still seems plausible that MmgB may act as a β-
hydroxyacyl-CoA dehydrogenase based on our initial investigation of sequence similarity 
and cofactor presence.  With the biochemical characterization of mmgC, mmgA15, and our 
initial results for mmgB, a strong argument can be made that the σE dependent mmg 
operon is used for energy production in sporulating Bacillus subtilis. 
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